Health apps fail in two predictable ways. Either the team treats it as an ordinary consumer app and discovers privacy and regulatory obligations after launch, or it treats every health related feature as maximally regulated and never ships. Getting the scope right early is largely a matter of answering two questions honestly: whose data is this, and does the app make a clinical claim.
Healthcare application development starts with whose data it is, and under which rules
If your app handles protected health information for or on behalf of a covered entity, the HIPAA Security Rule applies and its technical safeguards at 45 CFR 164.312 require access control, audit controls, integrity, authentication and transmission security. If it collects health data directly from consumers outside that relationship, HIPAA may not apply but other privacy obligations do. These are different architectures, particularly around logging and data retention, so settle the question before design rather than during a security review.
The line mHealth app developers cross between a wellness app and a regulated one
An app that tracks activity and encourages good habits is one thing; an app that interprets data to guide a clinical decision is another, and the second brings the device quality framework at 21 CFR part 820 into view along with everything that implies for documentation and change control. Teams cross this line accidentally, usually through a well meaning feature that offers an interpretation rather than a number. Write down where your line is and have your regulatory advisor confirm it before the feature is built.
How to read a healthcare mobile development cost estimate
Healthcare app development cost estimates diverge because bidders assume different answers to the two questions above, not because they disagree about screens. The underlying labour is ordinary: BLS reports a median annual wage of $135,980 for software developers in May 2025 and $104,300 for quality assurance analysts and testers. Ask each bidder to state its assumptions about HIPAA applicability, clinical claims and integration with any record system, then compare those assumptions first and the totals second.
The parts of custom health app development that are always more work than they look
Onboarding and identity, because you need confidence about who the user is before you show health data. Audit logging, because it has to be complete and tamper evident. Data deletion, because users will ask and platform rules increasingly require it. Offline behaviour, because people use these apps in hospitals with poor signal. None of these appear in a feature list and all of them appear in the schedule, so require them to be estimated explicitly.
Questions people ask about healthcare mobile app development
Does our health app need to be HIPAA compliant?
It depends whether you handle protected health information for or on behalf of a covered entity. If you do, the technical safeguards at 45 CFR 164.312 apply. If you collect health data directly from consumers outside that relationship, other privacy rules may govern instead. Get a written determination before design.
What drives healthcare app development cost most?
Not the screen count. It is whether HIPAA applies, whether the app makes a clinical claim, and whether it integrates with a record system. Those three answers can double or halve a quote, so make every bidder state its assumptions on each.
When does a health app become a regulated device?
Broadly, when it interprets data to inform a clinical decision rather than simply recording or displaying it. The distinction is consequential because it brings the quality management framework at 21 CFR part 820 into scope, so have it confirmed by a regulatory advisor rather than by your agency.
What should an mHealth app development company settle before it builds?
Two questions: whether the app handles protected health information for or on behalf of a covered entity, which brings the HIPAA Security Rule's technical safeguards at 45 CFR 164.312 into scope, and whether it interprets data to guide a clinical decision, which brings device regulation. Bidders who assume different answers produce estimates that cannot be compared.